Richard B. Mailman
Affiliations: | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Area:
dopamine neuropharmacologyWebsite:
http://www.med.unc.edu/psych/directories/mailman.htmGoogle:
"Richard Mailman"Mean distance: 17.08 (cluster 6)
Children
Sign in to add traineeAmy K. Jassen | grad student | 2003 | UNC Chapel Hill |
Sarah K. Leonard | grad student | 2004 | UNC Chapel Hill |
Karen L. Neitzel | grad student | 2004 | UNC Chapel Hill |
Jessica P. Ryman | grad student | 2004 | UNC Chapel Hill |
Scott H. Oloff | grad student | 2005 | UNC Chapel Hill |
Justin C. Fowler | grad student | 2006 | UNC Chapel Hill |
Jonathan D. Urban | grad student | 2006 | UNC Chapel Hill |
Justin T. Brown | grad student | 2008 | UNC Chapel Hill |
Thomas J. Walsh | post-doc | 1980-1986 | UNC Chapel Hill |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Cimino JX, Zhou M, Waxmonsky J, et al. (2023) Characterization of behavioral changes in T-maze alternation from dopamine D agonists with different receptor coupling mechanisms. Psychopharmacology |
Yang Y, Lewis MM, Huang X, et al. (2022) Dopamine D receptor-mediated β-arrestin signaling: Insight from pharmacology, biology, behavior, and neurophysiology. The International Journal of Biochemistry & Cell Biology. 148: 106235 |
Yang Y, Lewis MM, Kong L, et al. (2022) A dopamine D agonist vs. methylphenidate in modulating prefrontal cortical working memory. The Journal of Pharmacology and Experimental Therapeutics |
Weissenrieder JS, Reed JL, Moldovan GL, et al. (2021) Antipsychotic drugs elicit cytotoxicity in glioblastoma multiforme in a calcium-dependent, non-D receptor-dependent, manner. Pharmacology Research & Perspectives. 9: e00689 |
Mailman RB, Yang Y, Huang X. (2020) For Publication in The European Journal of Pharmacology D, not D, dopamine receptor activation dramatically improves MPTP-induced parkinsonism unresponsive to levodopa. European Journal of Pharmacology. 173760 |
Huang X, Lewis MM, Van Scoy LJ, et al. (2020) The D1/D5 Dopamine Partial Agonist PF-06412562 in Advanced-Stage Parkinson's Disease: A Feasibility Study. Journal of Parkinson's Disease |
Yang Y, Mailman RB. (2020) Dopamine D 1 Agonists, Working Memory, and the Prefrontal Cortex: Effect of Receptor Functional Selectivity/Signaling Bias The Faseb Journal. 34: 1-1 |
Weissenrieder JS, Neighbors JD, Mailman RB, et al. (2019) Cancer and the dopamine D2 receptor: a pharmacological perspective. The Journal of Pharmacology and Experimental Therapeutics |
Yang Y, Lee SM, Imamura F, et al. (2018) D1 dopamine receptors intrinsic activity and functional selectivity affect working memory in prefrontal cortex. Molecular Psychiatry |
Baladi MG, Forster MJ, Gatch MB, et al. (2018) Characterization of the neurochemical and behavioral effects of solriamfetol (JZP-110), a selective dopamine and norepinephrine reuptake inhibitor. The Journal of Pharmacology and Experimental Therapeutics |